We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immunoassay Evaluated for Severe Neurocysticercosis

By LabMedica International staff writers
Posted on 25 Mar 2013
The potential of the secreted metacestode antigen HP10 detection enzyme-linked immunosorbent assay (HP10 Ag-ELISA) has been evaluated in the long-term follow-up in the severe form of neurocysticercosis. More...


The assay performance was compared with that of Magnetic Resonance Imaging (MRI) and in addition, the robustness of the HP10 Ag-ELISA was evaluated independently at two different institutions.

Scientists at the National Autonomous University of Mexico (University City, Mexico) conducted a cohort trial involving 38 neurocysticercosis (NC) with cysticerci located in the subarachnoid space at the base of the brain (NC-SaB) cases and a total of 108 paired serum and cerebrospinal fluid (CSF) samples taken at intervals of four to eight months for up to 43 months. HP10 antigen was detected by Ag-ELISA and optical densities (OD) read at 450 nm and determined in ELISA processors, either the Benchmark Microplate Reader (Bio-Rad; Hercules, CA, USA) or the Opsys MR (Dynex Technologies; Chantilly, VA, USA).

A good level of agreement was found between positive/negative allocations for paired CSF and serum samples. There was complete agreement between radiological and CSF HP10 Ag-ELISA results in 18 out of the 38 cases. Of the 108-paired MRI/HP10 Ag-ELISA evaluations, agreement between MRI and CSF HP10 Ag-ELISA was found in 76 (70.4%) cases and between MRI and sera HP10 in 65 (60%) patients. This lack of agreement appears to be principally due to a misinterpreted MRI rather than to serum and/or CSF HP10 Ag-ELISA assay and in addition, HP10 Ag-ELISA proved to be a highly reproducible method, when comparing results obtained in two different Mexican institutions.

The authors concluded that the study established the usefulness and economic advantage of the HP10 Ag-ELISA applied on CSF and serum samples for the follow-up of patients with NC-SaB, the most severe form of the disease. They believe their results will lead to the rapid commercialization of a HP10 antigen diagnostic kit to favor its employment worldwide. The study was published on March 7, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

National Autonomous University of Mexico
Bio-Rad
Dynex Technologies



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.